Internis Pharmaceuticals

Internis Pharmaceuticals Overview

Founded 2010
Founded
Status Acquired/​Merged
Employees 32
Employees
Latest Deal Type M&A
Latest Deal Amount $76.8M
Latest Deal Amount

Internis Pharmaceuticals General Information

Description

Provider of vitamin D medicines. The company is engaged in the development and commercialization of medicines for the treatment of bone disorders like osteoporosis and vitamin D3 deficiency.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • Linthwaite Laboratories
  • West Yorkshire
  • Huddersfield HD7 5QH
  • England, United Kingdom
+44 01484 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Internis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Dec-2014 $76.8M 00.000 000.00 Completed Startup
1. Debt - General 10-Sep-2013 00.000 00.000 Completed Startup

Internis Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Charles Tannenbaum Co-Founder & Co-Chief Executive Officer
Martin Knight Co-Founder & Director
Alan Walker Ph.D Chief Executive Officer

Ready to get started?

Request a free trial